<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1409-4568</journal-id>
<journal-title><![CDATA[Enfermería Actual de Costa Rica]]></journal-title>
<abbrev-journal-title><![CDATA[Enfermería Actual de Costa Rica]]></abbrev-journal-title>
<issn>1409-4568</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Costa Rica ]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1409-45682017000100104</article-id>
<article-id pub-id-type="doi">10.15517/revenf.v0i32.27212</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Comparación entre ciprofloxacina y antibióticos de otros grupos farmacológicos para el tratamiento de infecciones del tracto urinario]]></article-title>
<article-title xml:lang="en"><![CDATA[Comparison between ciprofloxacine and antibiotics of other pharmacological groups for urinary tract infection treatment]]></article-title>
<article-title xml:lang="pt"><![CDATA[Comparação entre a ciprofloxacina e outros antibióticos grupos farmacológicos para o tratamento de infecções do tracto urinário]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arias Porras]]></surname>
<given-names><![CDATA[José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Caja Costarricense de Seguro Social  ]]></institution>
<addr-line><![CDATA[ San José]]></addr-line>
<country>CR</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<numero>32</numero>
<fpage>104</fpage>
<lpage>118</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_arttext&amp;pid=S1409-45682017000100104&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_abstract&amp;pid=S1409-45682017000100104&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_pdf&amp;pid=S1409-45682017000100104&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[ResumenIntroducción. Las infecciones de tracto urinario son un tema común en los servicios de consulta externa y emergencias de los centros de salud. El uso inadecuado e irracional de antibióticos puede favorecer la aparición de cepas resistentes y limitar la capacidad de respuesta de estos fármacos. Este artículo busca revisar el uso de quinolonas (específicamente ciprofloxacina) con antibióticos de otros grupos farmacológicos y comparar efectividad y resistencia bacteriana.Método. A partir de la metodología que señala la práctica clínica basada en la evidencia para las revisiones rápidas, se estableció una pregunta clínica a la que se le procuró responder mediante la búsqueda de investigaciones primarias en bases de datos electrónicas como MEDLINE, PubMed, Cochrane Library Plus y el Journal of Infection.Resultado. Según el tipo de bacteria y cepa analizada, hay presencia de resistencia a diversos antibióticos. Las infecciones de origen comunitario han sido tratadas con betalactámicos, nitrofurantoína, trimetoprimsulfametoxasol y fluoroquinolonas (especialmente ciprofloxacina).Conclusión. No se determinó si las quinolonas son más efectivas que los antibióticos que pertenecen a otros grupos farmacológicos]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[AbstractIntroduction. Urinary tract infections are a common reason of consultation in medical practical in ambulatory and emergency rooms in centers of health. The inadequate and irrational use of antibiotics can favor the appearance of resistant bacterial strain and limit the capacity of response of these medicines. This article seeks to review the use of quinolones (specifically ciprofloxacine) with antibiotics of other pharmacological groups and to compare efficiency and bacterial resistance.Method.From the methodology that indicates the clinical practice based on the evidence for the rapid reviews, there was established a clinical question to which response was tried to give by means of the search of primary investigations in electronic databases like MEDLINE, PubMed, Cochrane Library Plus and the Journal of Infection.Result. According to the type of bacterium and analyzed bacterial strain there is presence of resistance to diverse antibiotics. The infections of community origin have been treated by beta-lactamics, nitrofurantoine, trimetoprimsulfametoxasol and fluoroquinolones (specially ciprofloxacine).Conclusion. It was not possible to determine if the quinolonas are more effective than the antibiotics that belong to other pharmacological groups.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[ResumoIntrodução. As infecções do trato urinário são um tema comum nos serviços de consulta externa e emergências dos centros de saúde. O uso inadequado e irracional de antibióticos pode favorecer o aparecimento de cepas resistentes e limitar a capacidade de resposta destes medicamentos. Este artigo busca revisar o uso de quinolonas (especificamente ciprofloxacina) com antibióticos de outros grupos farmacológicos e comparar efetividade e resistência bacteriana.Método. A partir da metodologia que aponta a prática clínica baseada na evidência para as revisões rápidas, se estabeleceu uma pergunta clínica que se procurou responder mediante pesquisas primárias em bases de dados eletrônicas como MEDLINE, PubMed, Cochrane Library Plus e o Journal of Infection.Resultado. Segundo o tipo de bactéria e cepa analisada, há presença de resistência a diversos antibióticos. As infecções de origem comunitária tem sido tratadas com betalactâmicos, nitrofurantoína, trimetoprimsulfametoxasol e fluoroquinolonas (especialmente ciprofloxacina).Conclusão. Não se determinou se as quinolonas são mais eficazes que os antibióticos que pertencem a outros grupos farmacológicos]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[antibióticoprofilaxia]]></kwd>
<kwd lng="es"><![CDATA[ciprofloxacina]]></kwd>
<kwd lng="es"><![CDATA[infección-urinaria]]></kwd>
<kwd lng="es"><![CDATA[quinolonas]]></kwd>
<kwd lng="es"><![CDATA[resistencia-bacteriana-afármacos]]></kwd>
<kwd lng="en"><![CDATA[antibiotics]]></kwd>
<kwd lng="en"><![CDATA[bacterial-resistance]]></kwd>
<kwd lng="en"><![CDATA[ciprofloxacine]]></kwd>
<kwd lng="en"><![CDATA[quinolones]]></kwd>
<kwd lng="en"><![CDATA[urinary-infection]]></kwd>
<kwd lng="pt"><![CDATA[antibióticoprofilaxia]]></kwd>
<kwd lng="pt"><![CDATA[ciprofloxacina]]></kwd>
<kwd lng="pt"><![CDATA[infecção-urinária]]></kwd>
<kwd lng="pt"><![CDATA[quinolonas]]></kwd>
<kwd lng="pt"><![CDATA[resistência-bacteriana-amedicamentos]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Susceptibility to B-lactams and quinolones of Enterogacteriaceae isolated from urinary tract infections in outpatients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marchisio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Porto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Joris]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rico]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Baroni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Di Conza]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Brazilian Journal of Microb]]></source>
<year>2015</year>
<volume>46</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1155-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<collab>Caja Costarricense de Seguro Social</collab>
<source><![CDATA[Lista Oficial de Medicamentos y Normativa]]></source>
<year>2014</year>
<page-range>140-3</page-range><publisher-name><![CDATA[Dirección de Farmacoepidemiología]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petri]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sulfonamidas, Trimetoprim-Sulfametoxasol, Quinolonas y Fármacos contra infecciones de las vías urinarias]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Brunton]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lazo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Parker]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Goodman and Gilman. Las Bases Farmacológicas de la Terapéutica]]></source>
<year>2007</year>
<edition>11ma</edition>
<page-range>1111-25</page-range><publisher-loc><![CDATA[México D.F. ]]></publisher-loc>
<publisher-name><![CDATA[McGraw-Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Quinolonas. Perspectivas actuales y mecanismos de resistencia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez-Hernández]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Garza-Mayén]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Vásquez-López]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Chilena Infectol]]></source>
<year>2015</year>
<volume>32</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>499-504</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<collab>Centro de Investigación de Enfermedades Tropicales</collab>
<source><![CDATA[Resistencia a antibióticos]]></source>
<year>2016</year>
<publisher-name><![CDATA[Universidad de Costa Rica]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mecanismos de resistencia a quinolonas mediados por plásmidos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[Enferm Infecc Microbiol Clín]]></source>
<year>2005</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>25-31</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Urinary tract physiological conditions promote ciprofloxacina resistance in low-level quinolone resistant Escherichia coli]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Costas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Aznar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pascual]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Antimicrob Agents Chemother]]></source>
<year>2016</year>
<volume>60</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>4258</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Errecalde]]></surname>
<given-names><![CDATA[JO]]></given-names>
</name>
</person-group>
<source><![CDATA[Uso de antimicrobianos en animales de consumo]]></source>
<year>2004</year>
<publisher-name><![CDATA[Organización de las Naciones Unidas para la Agricultura y Alimentación FAO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="">
<collab>Organización Mundial para la Salud</collab>
<source><![CDATA[El primer informe mundial de la OMS sobre la resistencia a los antibióticos pone de manifiesto una grave amenaza para la salud pública en todo el mundo]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Antimicrobial agents for treating uncomplicated urinary tract infection in women]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zalmanovici]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Paul]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Yaphe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Leibovici]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Cochrane DS]]></source>
<year>2010</year>
<volume>10</volume>
<numero>CD007182</numero>
<issue>CD007182</issue>
<page-range>1-3</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[High rates of quinolone resistance among urinary tract infections in the ED]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khawcharoenpom]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Vasoo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Emerg Med]]></source>
<year>2012</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>68-74</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevalencia de gérmenes multirresistentes en infecciones de tracto urinario de la comunidad y asociadas a los cuidados de la salud]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Córdova]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lespada]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cecchini]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Jacob]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Gutfraind]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Badía]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Actualizaciones en SIDA e Infect.]]></source>
<year>2014</year>
<volume>22</volume>
<numero>84</numero>
<issue>84</issue>
<page-range>33-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic and meta-analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costelloe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Metcalfe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lovering]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mant]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[D Hay]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[BMJ]]></source>
<year>2010</year>
<volume>340</volume>
<numero>c2096</numero>
<issue>c2096</issue>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="book">
<collab>Organización Mundial para la Salud</collab>
<source><![CDATA[Resistencia a los antimicrobianos]]></source>
<year>2016</year>
<publisher-name><![CDATA[Centro de Prensa]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="">
<collab>Red Sudamericana de Atención Farmacéutica</collab>
<source><![CDATA[FDA: Alertas sobre fluorquinolonas]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="book">
<collab>Plan Nacional Resistencia a Antibióticos AEMPS</collab>
<source><![CDATA[Plan estratégico y de acción para reducir el riesgo de selección y diseminación de la resistencia a los antibióticos]]></source>
<year>2014</year>
<publisher-name><![CDATA[Ministerio de Sanidad, Servicios Sociales e Igualdad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="">
<collab>Instituto de Salud Carlos III</collab>
<source><![CDATA[Europa alerta del aumento de las resistencias antimicrobianas a antibióticos de última generación]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="">
<collab>Organización Mundial para la Salud</collab>
<source><![CDATA[Antimicrobial resistance: Global Report on Surveillance]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="">
<collab>Organización Panamericana para la Salud</collab>
<source><![CDATA[Plan de acción sobre la resistencia a los antimicrobianos]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Documento de consenso de la Asociación Española de Urología en el manejo de las infecciones del tracto urinario recurrentes no complicadas]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prieto]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Esteban]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Salinas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Adot]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Arlandis]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Peri]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Actas Urológicas Españolas]]></source>
<year>2015</year>
<volume>39</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>339-48</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
